U.S., May 24 -- ClinicalTrials.gov registry received information related to the study (NCT06988059) titled 'A Study of CT0596 in Plasma Cell Leukemia' on May 16.
Brief Summary: This study is a single-arm, open-label, exploratory dose-escalation and dosefinding clinical trial to evaluate the safety, efficacy, cellular pharmacokinetics and pharmacodynamics of CT0596 cells in patients with PCL.
Study Start Date: May 26
Study Type: INTERVENTIONAL
Condition:
Plasma Cell Leukemia
Intervention:
DRUG: CAR-T cells Infusion chimeric antigen receptor T cells
CAR-T cells Infusion
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Disclaimer: Curated by HT Syndication....